Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06290934

Last Updated: 2025-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE2

Total Enrollment

228 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-27

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to learn if GS-1427 is effective in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups treated with GS-1427 with participants treated with placebo.

The primary objective of this study is to assess the efficacy of GS-1427, compared with placebo control, in achieving clinical response at Week 12.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Part A, Part B, Part C: GS-1427 Dose A

Participants will receive GS-1427 Dose A Day 1 through Week 12 (Part A).

Participants who complete the 12-week Part A treatment period will be eligible to continue and remain on the same dose of GS-1427 through Week 52 (Part B).

Participants who complete Part B of the study will continue onto Part C: Blinded treatment extension for an additional 24 weeks (through Week 76).

Group Type EXPERIMENTAL

GS-1427

Intervention Type DRUG

Administered orally

Part A, Part B, Part C: GS-1427 Dose B

Participants will receive GS-1427 Dose B Day 1 through Week 12 (Part A).

Participants who complete the 12-week Part A treatment period will be eligible to continue and remain on the same dose of GS-1427 through Week 52 (Part B).

Participants who complete Part B of the study will continue onto Part C: Blinded treatment extension for an additional 24 weeks (through Week 76).

Group Type EXPERIMENTAL

GS-1427

Intervention Type DRUG

Administered orally

Part A, Part B, Part C: GS-1427 Dose C

Participants will receive GS-1427 Dose C Day 1 through Week 12 (Part A).

Participants who complete the 12-week Part A treatment period will be eligible to continue and remain on the same dose of GS-1427 through Week 52 (Part B).

Participants who complete Part B of the study will continue onto Part C: blinded treatment extension for an additional 24 weeks (through Week 76).

Group Type EXPERIMENTAL

GS-1427

Intervention Type DRUG

Administered orally

Part A, Placebo; Part B, Part C: GS-1427

Participants will receive Placebo to match GS-1427 Day 1 through Week 12 (Part A). Part A placebo participants will be eligible to undergo re-randomization in a double-blind manner after endoscopy assessment at Week 12 to receive one of the GS-1427 dose A, B, or C treatments.

Participants will be eligible to continue and remain on the new dose through Week 52 (Part B). Participants who complete Part B of the study will continue onto Part C: blinded treatment extension for an additional 24 weeks (through Week 76).

Group Type EXPERIMENTAL

GS-1427

Intervention Type DRUG

Administered orally

Placebo-to-match GS-1427

Intervention Type DRUG

Administered orally

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GS-1427

Administered orally

Intervention Type DRUG

Placebo-to-match GS-1427

Administered orally

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals have Ulcerative Colitis (UC) with symptoms of at least 90 days duration before randomization, with the diagnosis confirmed by endoscopy and histology at any time prior to randomization. Documentation of endoscopy and histology consistent with the diagnosis of UC must be available in the source documents.
* Individuals have UC with minimum disease extent of 15 cm from the anal verge.
* Individuals have moderately to severely active UC as determined by endoscopy occurring during screening with a total modified Mayo Clinic Score (mMCS) of 5 to 9 points, including a centrally read endoscopic subscore of at least 2.
* Individuals have an inadequate response or loss of response or are intolerant to at least 1 of the following UC treatments: corticosteroids, immunomodulators, or advanced therapy.
* Individuals have an inadequate response or loss of response or are intolerant to \< 3 AT mechanisms of action for UC (use of 2 or more AT with the same mechanism of action, eg, 2 TNF-α inhibitors, counts as 1 mechanism of action)

Exclusion Criteria

* Have a current diagnosis of Crohn's Disease (CD) or clinical findings suggestive of CD, diagnosis of indeterminate colitis due to etiologies such as an enteric pathogen, or lymphocytic or collagenous colitis.
* Have a current diagnosis of toxic megacolon, symptomatic colonic stricture, acute severe colitis, fulminant colitis, or abdominal abscess at screening or randomization.
* Have any history of exposure to vedolizumab or other integrin antagonists
* Requirement for ongoing therapy with or use of any prohibited medication as specified in the protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gilead Sciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gilead Study Director

Role: STUDY_DIRECTOR

Gilead Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Onyx Clinical Research (Clinic Location)

Peoria, Arizona, United States

Site Status

Om Research LLC

Camarillo, California, United States

Site Status

VVCRD Research

Garden Grove, California, United States

Site Status

310 Clinical Research

Inglewood, California, United States

Site Status

US San Diego Health System

La Jolla, California, United States

Site Status

Om Research LLC

Lancaster, California, United States

Site Status

UCSF Benioff Children's Hospital Oakland

Oakland, California, United States

Site Status

University Of California, Davis

Sacramento, California, United States

Site Status

SDG Clinical Research, LLC

San Diego, California, United States

Site Status

Acclaim Clinical Research

San Diego, California, United States

Site Status

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States

Site Status

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States

Site Status

Gastro Florida

Clearwater, Florida, United States

Site Status

Best Quality Research, Inc

Hialeah, Florida, United States

Site Status

United Research Institute LLC

Hialeah, Florida, United States

Site Status

University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center(Drug shipment)-Research Pharmacy

Miami, Florida, United States

Site Status

Medical Professional Clinical Research Center, Inc.

Miami, Florida, United States

Site Status

Blessed Health Care & Research, Inc

Miami, Florida, United States

Site Status

Alliance Clinical Research of Tampa, LLC

New Port Richey, Florida, United States

Site Status

Digestive and Liver Center of Florida, LLC

Orlando, Florida, United States

Site Status

Clinical Research of Osceola

Orlando, Florida, United States

Site Status

Encore Medical Research of Weston, LLC

Weston, Florida, United States

Site Status

EBGS Clinical Research Center

Snellville, Georgia, United States

Site Status

The University of Chicago Medical Center (Duchossois Center for Advanced Medicine)

Chicago, Illinois, United States

Site Status

Onyx Clinical Research

Peoria, Illinois, United States

Site Status

Robley Rex VA Medical Center

Louisville, Kentucky, United States

Site Status

Louisiana Research Center, LLC

Shreveport, Louisiana, United States

Site Status

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, United States

Site Status

Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center.

Wyoming, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Gastroenterology Associates of North Mississippi

Oxford, Mississippi, United States

Site Status

Digestive Health Specialists (Clinic Visits)

Tupelo, Mississippi, United States

Site Status

St Charles Clinical Research

Weldon Spring, Missouri, United States

Site Status

Tandem - Allied Clinical Research, LLC

Freehold, New Jersey, United States

Site Status

N.Y. Total Medical Care, PC

Brooklyn, New York, United States

Site Status

NYU Langone Long Island Clinical Research Associates

Great Neck, New York, United States

Site Status

Lenox Hill Hospital

Manhasset, New York, United States

Site Status

NYU Grossman School of Medicne

New York, New York, United States

Site Status

Carolina Research

Greenville, North Carolina, United States

Site Status

Piedmont Healthcare

Statesville, North Carolina, United States

Site Status

Dayton Gastroenterology, LLC

Beavercreek, Ohio, United States

Site Status

Gastro Health Research

Cincinnati, Ohio, United States

Site Status

NexGen Research

Lima, Ohio, United States

Site Status

Gastro Intestinal Research Institute of Northern Ohio, LLC

Westlake, Ohio, United States

Site Status

Penn State University Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Skyline gastroenterology of west Tennessee

Jackson, Tennessee, United States

Site Status

Quality Medical Research

Nashville, Tennessee, United States

Site Status

Vanderbilt Inflammatory Bowel Disease Clinic

Nashville, Tennessee, United States

Site Status

Gastroenterology Research of San Antonio

Fredericksburg, Texas, United States

Site Status

Amel Med Llc

Georgetown, Texas, United States

Site Status

GI Alliance - Mansfield

Mansfield, Texas, United States

Site Status

Clinical Associates in Research Therapeutics of America, LLC

San Antonio, Texas, United States

Site Status

Southern Star Research Institute, LLC.

San Antonio, Texas, United States

Site Status

Tyler Research Institute, LLC.

Tyler, Texas, United States

Site Status

University of Virginia Medical Center

Charlottesville, Virginia, United States

Site Status

Emeritas Research Group

Lansdowne Town Center, Virginia, United States

Site Status

Gastroenterology Consultants of Southwest Virginia

Roanoke, Virginia, United States

Site Status

Macquarie University

Sydney, New South Wales, Australia

Site Status

Mater Adult Hospital - Mater Misericordiae Ltd and Mater Research Ltd

South Brisbane, Queensland, Australia

Site Status

Princess Alexandra Hospital - Metro South Health

Woolloongabba, Queensland, Australia

Site Status

The Queen Elizabeth Hospital

Woodville, South Australia, Australia

Site Status

Monash Health - Monash Medical Centre

Clayton, Victoria, Australia

Site Status

Northern Hospital - Northern Health

Epping, Victoria, Australia

Site Status

Saint Vincent's Hospital Melbourne

Fitzroy, Victoria, Australia

Site Status

Footscray Hospital - Westerm Health

Footscray, Victoria, Australia

Site Status

Medical University Innsbruck, University Hospital for Internal Medicine I

Innsbruck, , Austria

Site Status

Regional Hospital Salzburg, University Clinic for Internal Medicine I

Salzburg, , Austria

Site Status

Medical University Vienna, Department of Internal Medicine Division Gastroenterology and Hepatology

Vienna, , Austria

Site Status

Imeldaziekenhuis

Bonheiden, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

Vitaz

Sint-Niklaas, , Belgium

Site Status

TDDA Specialty Reserach

Vaughan, , Canada

Site Status

PreventaMed, s.r.o.

Olomouc, , Czechia

Site Status

Nemocnice Slany

Slaný, , Czechia

Site Status

Centre Hospitalier Universitaire Grenoble Alpes(CHUGA) - Service Hepato-Gastroentérologie, 7éme unité D

La Tronche, , France

Site Status

CHU Nantes Gastroenterology department

Nantes, , France

Site Status

Hospices Civilis de Lyon - Hospital Lyon Sud Department of Gastroenterology

Pierre-Bénite, , France

Site Status

ARENSIA Exploratory Medicine

Tbilisi, , Georgia

Site Status

Universitatsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik |

Dresden, , Germany

Site Status

Studiengesellschaft BSF UG

Halle, , Germany

Site Status

University Hospital Schleswig-Holstein, Clinic for Internal Medicine

Kiel, , Germany

Site Status

Ulm University Hospital, Centre for Internal Medicine I

Ulm, , Germany

Site Status

Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Princess Margaret Hospital

Hong Kong, , Hong Kong

Site Status

Békés Varmegye Kozponti Korhaz, dr Rethy Pal 4. Belgyégyaszat - Gasztroenterologia

Békéscsaba, , Hungary

Site Status

Semmelweis Egyetem AOK

Budapest, , Hungary

Site Status

Semmelweis Egyetem Általanos Orvostudományi Kar

Budapest, , Hungary

Site Status

Clinexpert Gyógycentrum

Budapest, , Hungary

Site Status

Azienda Ospedaliero-Universitaria Di Bologna IRCCS

Bologna, , Italy

Site Status

Azienda Ospedaliera Brotzu - P.O. San Michele

Cagliari, , Italy

Site Status

AOU "Renato Dulbecco" - Digestive Physiopathology Unit

Catanzaro, , Italy

Site Status

San Raffaele Hospital IRCCS

Milan, , Italy

Site Status

IRCCS Ospedale Sacro Cuore Don Calabria

Negrar, , Italy

Site Status

Azienda Ospedale Universita di Padova

Padua, , Italy

Site Status

AOOR Villa Sofia- Cervello

Palermo, , Italy

Site Status

Campus Biomedico University Hospital Foundation

Roma, , Italy

Site Status

Ospedale Sandro Pertini

Roma, , Italy

Site Status

IRCCS Policlinico San Donato

San Donato Milanese, , Italy

Site Status

Ospedale Casa Sollievo della Sofferenza IRCCS, Opera di San Pio da Pietrelcina

San Giovanni Rotondo, , Italy

Site Status

Azienda Ospedaliera Ordine Mauriziano di Torino

Torino, , Italy

Site Status

Hospital Sultanah Aminah

Johor Bahru, , Malaysia

Site Status

Hospital Universiti Sains Malaysia

Kelantan, , Malaysia

Site Status

Hospital Queen Elizabeth

Kota Kinabalu, , Malaysia

Site Status

Hospital Sultan Idris Shah Serdang

Kuala Selangor, , Malaysia

Site Status

Hospital Tengku Ampuan Afzan

Kuantan, , Malaysia

Site Status

Sultan Ahmad Shah Medical Centre @IIUM

Kuantan, , Malaysia

Site Status

University Malaya Medical Centre

Petaling Jaya, , Malaysia

Site Status

PMSI Clinical Republican Hospital "Timofei Molneaga"

Chisinau, , Moldova

Site Status

Pacific Clinical Research Network - Auckland

Auckland, , New Zealand

Site Status

Christchurch Hospital

Christchurch, , New Zealand

Site Status

Health New Zealand - Te Whatu Ora Southern, Gastroenterology Department, Dunedin Hospital

Dunedin, , New Zealand

Site Status

Centrum Medyczne "Medis"

Bydgoszcz, , Poland

Site Status

NZOZ Holsamed - Oddzial Libero

Katowice, , Poland

Site Status

Centrum Medyczne Plejady Magdalena Celinska Loewenhoff Michal Zolnowski sp.k.

Krakow, , Poland

Site Status

Krakowskie Centrum Medyczne Sp. z o.o.

Krakow, , Poland

Site Status

Centrum Opieki Zdrowotnej Orkan-Med Stec-Michalska Sp. J.

Ksawerów, , Poland

Site Status

Medrise Sp. z o.o.

Lublin, , Poland

Site Status

Centrum Innowacyjnych Terapii Sp. z o.o.

Mazowieckie, , Poland

Site Status

EMC Instytut Medyczny SA PL Certus Szpital Nr 1 PL Certus Ambulatorium

Poznan, , Poland

Site Status

Gabinety Lekarskie RIVERMED

Poznan, , Poland

Site Status

Centrum Medyczne Medyk Sp. z 0.0. sp.k.

Rzeszów, , Poland

Site Status

Endoskopia Sp. z.o.o.

Sopot, , Poland

Site Status

Sonomed Sp. z 0.0.

Szczecin, , Poland

Site Status

Twoja Przychodnia Szczecinskie Centrum Medyczne Sp. zo.o.

Szczecin, , Poland

Site Status

Gastromed Sp. z.o.o.

Torun, , Poland

Site Status

H-T Centrum Medyczne - Endoterapia

Tychy, , Poland

Site Status

Bodyclinic Sp. z o.o. sp.k.

Warsaw, , Poland

Site Status

Przychodnia care Access Warsawa

Warsaw, , Poland

Site Status

Medical Network Sp. z 0.0. WIP Warsaw IBD Point Profesor Kierkus

Warsaw, , Poland

Site Status

Niepubliczny Zaklad Opieki Zdrowotnej Vivamed Jadwiga Miecz

Warsaw, , Poland

Site Status

FutureMeds Wrocław

Wroclaw, , Poland

Site Status

Centrum Medyczne Oporow

Wroclaw, , Poland

Site Status

Przychodnia Euromedicare szpital euromedicare

Wroclaw, , Poland

Site Status

Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila

Bucharest, , Romania

Site Status

Spitalul Clinic Colentina

Bucharest, , Romania

Site Status

Institutul Clinic Fundeni

Bucharest, , Romania

Site Status

Centrul Medical Medicum S.R.L.

Bucharest, , Romania

Site Status

Centrul Medical Monza S.R.L

Bucharest, , Romania

Site Status

Spitalul Clinic Judetean De Urgenta Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Institutul Regional De Gastroenterologie Hepatologie Prof. Dr. Octavian Fodor Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Gastromed S.R.L

Constanța, , Romania

Site Status

Spitalul Judetean de Urgenta Satu Mare

Satu Mare, , Romania

Site Status

Asociatia Oncohelp

Timișoara, , Romania

Site Status

Centrul De Gastroenterologie Dr. Goldis S.R.L

Timișoara, , Romania

Site Status

Clinical Hospital Center "Bezanijska Kosa", Clinic for Internal Medicine, Gastroenterology and Hepatology Department

Belgrade, , Serbia

Site Status

Clinical Hospital Center "Dr Dragisa Misovic - Dedinje" Clinic for Intemal Medicine, Gastroentero logy and Hepatology Department

Belgrade, , Serbia

Site Status

Clinical Hospital Center "Zvezdara" - Belgrade, Clinic for Internal Diseases Clinical Department of Gastroenterology and Hepatology

Belgrade, , Serbia

Site Status

University Clinical Center of Serbia, Clinic for Gastroenterology and Hepatology

Belgrade, , Serbia

Site Status

University Clinical Center Kragujevac, Clinic for Gastroenterology and Hepatology

Kragujevac, , Serbia

Site Status

General Hospital "Djordje Joanovic" Zrenjanin,Internal Medicine Sector - Internal Department

Zrenjanin, , Serbia

Site Status

Inje University Haeundae Paik Hospital IRB

Busan, , South Korea

Site Status

Kyungpook National University Hospital

Daegu, , South Korea

Site Status

The Catholic University of Korea Daejeon St.Mary's Hospital

Daejeon, , South Korea

Site Status

Kyung Hee University Hospital

Guri-si, , South Korea

Site Status

Kangbuk Samsung Hospital

Jongno-Gu, , South Korea

Site Status

Yeungnam University Hospital

Nam-Gu, , South Korea

Site Status

Hanyang University Seoul Hospital

Seongdong-gu, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

The Catholic University of Korea, Seoul St. Mary's Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea

Suwon, , South Korea

Site Status

Yonsei University Wonju Severance Christian Hospital

Wŏnju, , South Korea

Site Status

Hospital Arquitecto Marcide. Complejo Hospitalario Universitario de Ferrol

Ferrol, , Spain

Site Status

Hospital Universitario de Cabuenes

Gijón, , Spain

Site Status

Hospital Universitario Juan Ramon Jimenez

Huelva, , Spain

Site Status

Hospital Universitario Nuestra Senora de Candelaria

Santa Cruz de Tenerife, , Spain

Site Status

Hospital Universitario Virgen Macarena

Seville, , Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, , Spain

Site Status

Changhua Christian Hospital

Changhua, , Taiwan

Site Status

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

China Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, ZIP 100

Taipei, , Taiwan

Site Status

MacKay Memorial Hospital

Taipei, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Chang Gung Memorial Hospital (CGMH)

Taoyuan, , Taiwan

Site Status

Southmead Hospital - North Bristol Trust Clinical Research Centre

Bristol, , United Kingdom

Site Status

Fairfield General Hospital, Northerncare Alliance NHS Foundation Trust

Bury, , United Kingdom

Site Status

Cambridge University Hospital NHS Trust, Addenbrookes Hospital

Cambridge, , United Kingdom

Site Status

Synexus Clinical Research Centre

Cardiff, , United Kingdom

Site Status

King's College Hospital

London, , United Kingdom

Site Status

Northumbria Healthcare NHS Foundation Trust, North Tyneside General Hospital

North Shields, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Austria Belgium Canada Czechia France Georgia Germany Hong Kong Hungary Italy Malaysia Moldova New Zealand Poland Romania Serbia South Korea Spain Taiwan United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-508304-38

Identifier Type: OTHER

Identifier Source: secondary_id

GS-US-409-5704

Identifier Type: -

Identifier Source: org_study_id